These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 20851307

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [Abstract] [Full Text] [Related]

  • 3. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
    Beavers KM, Beavers DP, Bowden RG, Wilson RL, Gentile M.
    Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
    [Abstract] [Full Text] [Related]

  • 4. Marine n-3 polyunsaturated fatty acids in patients with end-stage renal failure and in subjects without kidney disease: a comparative study.
    Madsen T, Christensen JH, Svensson M, Witt PM, Toft E, Schmidt EB.
    J Ren Nutr; 2011 Mar; 21(2):169-75. PubMed ID: 20833075
    [Abstract] [Full Text] [Related]

  • 5. Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patients.
    Kirkegaard E, Svensson M, Strandhave C, Schmidt EB, Jørgensen KA, Christensen JH.
    Br J Nutr; 2012 Mar; 107(6):903-9. PubMed ID: 21791142
    [Abstract] [Full Text] [Related]

  • 6. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure.
    Madsen T, Schmidt EB, Christensen JH.
    J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424
    [Abstract] [Full Text] [Related]

  • 7. Effect of omega 3 and omega 6 fatty acid intakes from diet and supplements on plasma fatty acid levels in the first 3 years of life.
    Hoyos C, Almqvist C, Garden F, Xuan W, Oddy WH, Marks GB, Webb KL.
    Asia Pac J Clin Nutr; 2008 Jul; 17(4):552-7. PubMed ID: 19114389
    [Abstract] [Full Text] [Related]

  • 8. Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.
    Young GS, Conquer JA, Thomas R.
    Reprod Nutr Dev; 2005 Jul; 45(5):549-58. PubMed ID: 16188207
    [Abstract] [Full Text] [Related]

  • 9. Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality.
    Masson S, Marchioli R, Mozaffarian D, Bernasconi R, Milani V, Dragani L, Tacconi M, Marfisi RM, Borgese L, Cirrincione V, Febo O, Nicolis E, Maggioni AP, Tognoni G, Tavazzi L, Latini R.
    Am Heart J; 2013 Feb; 165(2):208-15.e4. PubMed ID: 23351824
    [Abstract] [Full Text] [Related]

  • 10. Elevated homocysteine levels in patients with end-stage renal disease.
    Nair AP, Nemirovsky D, Kim M, Geer EB, Farkouh ME, Winston J, Halperin JL, Robbins MJ.
    Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
    [Abstract] [Full Text] [Related]

  • 11. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination.
    Zeman M, Zák A, Vecka M, Tvrzická E, Písaríková A, Stanková B.
    J Nutr Biochem; 2006 Jun; 17(6):379-84. PubMed ID: 16214329
    [Abstract] [Full Text] [Related]

  • 12. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
    Heinz J, Kropf S, Luley C, Dierkes J.
    Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
    [Abstract] [Full Text] [Related]

  • 13. The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis.
    Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
    J Ren Nutr; 2007 Jul; 17(4):243-9. PubMed ID: 17586422
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Three-year tracking of fatty acid composition of plasma phospholipids in healthy children.
    Guerra A, Demmelmair H, Toschke AM, Koletzko B.
    Ann Nutr Metab; 2007 Jul; 51(5):433-8. PubMed ID: 18025816
    [Abstract] [Full Text] [Related]

  • 16. Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study.
    Saifullah A, Watkins BA, Saha C, Li Y, Moe SM, Friedman AN.
    Nephrol Dial Transplant; 2007 Dec; 22(12):3561-7. PubMed ID: 17623719
    [Abstract] [Full Text] [Related]

  • 17. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men.
    Poudel-Tandukar K, Nanri A, Matsushita Y, Sasaki S, Ohta M, Sato M, Mizoue T.
    Nutr Res; 2009 Jun; 29(6):363-70. PubMed ID: 19628101
    [Abstract] [Full Text] [Related]

  • 18. Change in the fatty acid pattern of erythrocyte membrane phospholipids after oral supplementation of specific fatty acids in patients with gastrointestinal diseases.
    Siener R, Alteheld B, Terjung B, Junghans B, Bitterlich N, Stehle P, Metzner C.
    Eur J Clin Nutr; 2010 Apr; 64(4):410-8. PubMed ID: 20160750
    [Abstract] [Full Text] [Related]

  • 19. Supplementation with fish oil affects the association between very long-chain n-3 polyunsaturated fatty acids in serum non-esterified fatty acids and soluble vascular cell adhesion molecule-1.
    Berstad P, Seljeflot I, Veierød MB, Hjerkinn EM, Arnesen H, Pedersen JI.
    Clin Sci (Lond); 2003 Jul; 105(1):13-20. PubMed ID: 12589702
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease.
    Sahinarslan A, Güz G, Okyay K, Mutluay R, Yalçin R, Bali M, Sindel S, Cengel A.
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):382-7. PubMed ID: 19155641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.